Yea Seong Ryu

Asan Medical Center — South Korea

Medicine · Health Sciences

20h-index1.7kcitations64works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(25), Cytokine Signaling Pathways and Interactions(23), interferon and immune responses(14), Ferroptosis and cancer prognosis(8), Skin Protection and Aging(7)

Publications64 total

Secreted AZGP1 induced by 5-FU binds to PD-L1 and promotes apoptosis in cholangiocarcinoma
Molecular Medicine·2025Open Access
TP53 and DNA-PK as potential biomarkers for enhanced efficacy of Olaparib in colorectal cancer
Investigational New Drugs·2025· 2 cited
Inactivation of VRK1 sensitizes ovarian cancer to PARP inhibition through regulating DNA-PK stability
Experimental Cell Research·2024· 1 cited
Supplementary Table 2 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Table 1 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Table 1 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 5 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 1 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 7 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 7 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 3 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Data from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 3 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 2 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 4 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 8 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Table 2 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 4 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Supplementary Figure 6 from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
Data from The Immune Suppressor IGSF1 as a Potential Target for Cancer Immunotherapy
2024Open Access
page 1 of 4Next →

Frequent Co-authors

Mei Jing Piao(25), Jin Won Hyun(25), Kyoung Ah Kang(24), Dong‐In Koh(23), Dong‐Hoon Jin(21), Jun Ki Hong(16), Joseph Kim(14), Seunggeon Bae(13), Yoon Sun Park(13), Minki Lee(12), Mi So Lee(12), Jun Hyung Lee(12), Mingee Choi(12), Jae-Sik Shin(11), Hong-Rae Jeong(11), Seung-Woo Hong(11), Dong Kwan Kim(11), Hyun-Kyung Lee(11), Bomi Kim(11), Yoo Sang Yoon(11)